MOTS-c 10mg

What is MOTS-c 10mg?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA, classified as an injectable peptide in this 10 mg vial from Dragon Pharma. It's used in fitness and wellness for its metabolic and energy-enhancing properties. Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water, it has no hepatotoxicity, no aromatization, and minimal side effects when used responsibly.

Mechanism of Action MOTS-c

MOTS-c activates AMP-activated protein kinase (AMPK), enhancing glucose uptake, fat oxidation, and mitochondrial biogenesis. It translocates to the nucleus under metabolic stress, regulating genes for cellular resilience and insulin sensitivity. Users notice improved energy, fat loss, and metabolic efficiency within weeks.

With a half-life of approximately 4-6 hours, MOTS-c requires daily injections for optimal effects. It doesn't interact with androgenic or estrogenic pathways, ensuring no hormonal disruptions. What doesn't happen: no HPTA suppression, no water retention, and no liver toxicity, making it ideal for metabolic protocols.

Mild injection site reactions may occur, manageable with proper technique and dosing.

How It Works & Key Benefits

MOTS-c excels for athletes and wellness enthusiasts seeking fat loss, energy, and metabolic health, requiring a calorie-controlled diet and exercise to maximize its effects.

• Promotes fat loss by enhancing fat oxidation.
• Boosts energy for sustained training performance.
• Improves insulin sensitivity for metabolic health.
• Supports mitochondrial function and anti-aging.
• Enhances glucose disposal for better nutrient use.
• Stacks well with other peptides or fat burners.

Who It's For & Product Specifications

Best for athletes, bodybuilders, and individuals seeking metabolic optimization and fat loss; suitable for men and women due to its non-hormonal profile. Not recommended for those with peptide allergies or without injection knowledge.

How to Use

1. Dosage: 5-10 mg/week, split into daily injections of 0.7-1.4 mg; start at 5 mg/week to assess tolerance.
2. Cycle length: 4-8 weeks, with breaks to maintain efficacy.
3. Preparation/Monitoring tips: Reconstitute with 2 ml bacteriostatic water for 5 mg/ml; use insulin syringes; store refrigerated; monitor for injection site reactions; maintain a low-carb, high-protein diet.
4. Results timeline: Energy and fat loss in 1-2 weeks; metabolic improvements in 4-6 weeks.
5. PCT timing: Not required as MOTS-c doesn't suppress hormones; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester).

Popular Stacks

BPC-157: Enhances recovery and tissue repair.

GW 501516: Boosts fat loss and endurance synergy.

CJC-1295: Supports GH release for complementary vitality.

Cycle Support: Enhances overall wellness during protocols.

Comparisons & Alternatives

MOTS-c vs BPC-157: MOTS-c focuses on metabolic health and fat loss; BPC-157 targets localized tissue repair.

MOTS-c vs GW 501516: MOTS-c enhances mitochondrial function; GW 501516 boosts endurance via PPAR activation.

MOTS-c vs Semaglutide: MOTS-c targets mitochondrial pathways; Semaglutide focuses on GLP-1 for appetite control.

Side Effects & Risk Management

• Dermatologic: Mild injection site redness—use sterile technique, rotate sites.
• Systemic: Rare fatigue or headaches—lower dose if occurs.
• Endocrine: None; no hormonal suppression.
• Cardiometabolic: None; no significant BP or lipid impact.
• Joint & Tendon: None; supports metabolic health.

Review administration with a professional where lawful to ensure authenticity and proper dosing for safety. MOTS-c is not FDA-approved for human use and is sold for research purposes only.

Post-Cycle Therapy (PCT)

MOTS-c requires no PCT as it doesn't suppress testosterone or HPTA; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester). Use tamoxifen or clomiphene for 4 weeks if needed, guided by bloodwork.